drugset / Trial / NCT01453855
Travoprost 3-Month Safety and Efficacy Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study was to demonstrate that the intraocular pressure-lowering efficacy of Travoprost 0.003% is equivalent to TRAVATAN® in adult patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | 0.003 % | Other |
| Subject | Travoprost | Other / unclassified | 0.004 % | Other |